EMPAGLIFLOZIN + LINAGLIPTIN
empagliflozin 25 mg + linagliptin 5 mg tablet, 30
EMPAGLIFLOZIN + LINAGLIPTIN (13958P)
13958P
Manner of administration:Oral
Restriction (Streamlined authority code: 15270)
Indication: Diabetes mellitus type 2
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $143.62 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Glyxambi | |||||
